… metabolism between leukemia stem cells and malignant stem cells from solid tumors. …
malignant stem cells from solid tumors. Because metabolic properties are highly specific to the cell …

… Cancer stem cells (CSCs) are highly tumorigenic cell types that reside within specific
areas of tumor microenvironment (TME), and are endowed with self-renewal and resistance …

… In conclusion, CD55 has been shown to promote cancer stem cell characteristics in multiple
forms of cancer, highlighting its significance in tumorigenesis and aggressive disease. The …

… More than 500 papers were scanned for this review by searching the keywords “cancer
stem cells” and “cancer,” among them approximately 100 papers have pursued the criteria for …

… The first humanised anti-CD47 monoclonal antibody, Hu5F9-G4, was administered to
patients with various solid tumours in a phase I clinical trial (NCT02216409). The trial aimed at …

… in solid tumors, including CD133 in a wide variety of cancers, Sox2 in glioblastoma, ALDH1
in breast and GI cancers, LGR5 in colon cancer, and CD44 in breast cancer, … of the stem cell …

… The aggressive nature of certain solid tumors is thought to result, at least in part, from the
expansion of cancer stem cell (CSC) populations with self-renewal and differentiation …

… PDAC solid tumors are comprised of a wide range of heterogeneous populations of … cancer
stem cell initiation from iPSCs, our group demonstrated that pancreatic cancer stem-like cells, …

… (BCSCs) were first identified in 2003 based on the expression levels of cell surface … cell
behavior. Scientists demonstrated that CD44 and its isoforms are reliable cancer stem cell …

… Cytotoxic therapies are currently used for the treatment of solid tumors and hematological
malignancies in the absence of other first-line, effective and less toxic treatments. Beside the …